The Food & Drug Administration capped its regulatory efforts to make two-piece gelatin OTC capsules harder to tamper with by requiring manufacturers to seal capsules and to use at least one "tamper-evident" packaging feature.
Responding to a petition by soy protein maker Protein Technologies Intl., the Food and Drug Administration has proposed new health claims linking soy protein with a reduction in coronary heart disease.
New software helps SmithKline Beecham comply with FDA GMPs for creating and disseminating packaging specifications. Software permits validation of packaging spec dissemination process, virtually eliminating exposure to compliance violations. Part one of two.
Many types of household products sporting "antibacterial" labels are being snapped up by germ-wary consumers, but there is growing concern among government regulators and health professionals that many labels are misleading.